SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-19-008565
Filing Date
2019-11-12
Accepted
2019-11-12 16:41:00
Documents
2
Period of Report
2019-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_111219.htm 8-K 28049
2 PRESS RELEASE ISSUED NOVEMBER 12, 2019 ex99-1.htm EX-99.1 24983
  Complete submission text file 0001387131-19-008565.txt   54281
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 191210240
SIC: 2834 Pharmaceutical Preparations